Fate Therapeutics
(NASDAQ:FATE)
$20.41
0.57[2.87%]
Last update: 2:38PM (Delayed 15-Minutes)
Get Real Time Here
Day Range19.41 - 20.5752 Wk Range17.1 - 66.56Open / Close19.98 / -Float / Outstanding72.7M / 97.2M
Vol / Avg.645K / 1.3MMkt Cap2BP/E-50d Avg. Price21.03
Div / Yield-Payout Ratio-Total Float72.7MEPS-0.86

Fate Therapeutics Stock (NASDAQ:FATE), Quotes and News Summary

Fate Therapeutics Stock (NASDAQ: FATE) stock price, news, charts, stock research, profile.

Loading...
Day Range19.41 - 20.5752 Wk Range17.1 - 66.56Open / Close19.98 / -Float / Outstanding72.7M / 97.2M
Vol / Avg.645K / 1.3MMkt Cap2BP/E-50d Avg. Price21.03
Div / Yield-Payout Ratio-Total Float72.7MEPS-0.86
Seeking Alpha - Nov 10, 2022, 12:02PM
Seeking Alpha - Oct 5, 2022, 11:43PM
InvestorsObserver - Aug 31, 2022, 3:38PM
InvestorPlace - Aug 15, 2022, 2:56PM
Sector: Health Care.Industry: Biotechnology
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and immune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-27
REV
Q3 2022Est.ActualSurprise
EPS-0.890-0.860 0.0300
REV15.630M14.981M-649.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Fate Therapeutics (FATE) stock?

A

You can purchase shares of Fate Therapeutics (NASDAQ: FATE) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Fate Therapeutics's (FATE) competitors?

Q

What is the target price for Fate Therapeutics (FATE) stock?

A

The latest price target for Fate Therapeutics (NASDAQ: FATE) was reported by Citigroup on Wednesday, November 16, 2022. The analyst firm set a price target for 80.00 expecting FATE to rise to within 12 months (a possible 291.96% upside). 14 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Fate Therapeutics (FATE)?

A

The stock price for Fate Therapeutics (NASDAQ: FATE) is $20.41 last updated Today at November 30, 2022, 7:38 PM UTC.

Q

Does Fate Therapeutics (FATE) pay a dividend?

A

There are no upcoming dividends for Fate Therapeutics.

Q

When is Fate Therapeutics (NASDAQ:FATE) reporting earnings?

A

Fate Therapeutics’s Q4 earnings are confirmed for Monday, February 27, 2023.

Q

Is Fate Therapeutics (FATE) going to split?

A

There is no upcoming split for Fate Therapeutics.

Q

What sector and industry does Fate Therapeutics (FATE) operate in?

A

Fate Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.